{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:24:12Z","timestamp":1771889052954,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2047094"],"award-info":[{"award-number":["2047094"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.josat.2025.209749","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:19:24Z","timestamp":1750940364000},"page":"209749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of telehealth, in-person, and hybrid care modalities on buprenorphine discontinuation among patients with opioid use disorder: A retrospective cohort study on commercially insured individuals"],"prefix":"10.1016","volume":"176","author":[{"given":"Jabed Al","family":"Faysal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md.","family":"Noor-E-Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Yaseliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie J.","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Mahmudul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209749_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108493","article-title":"An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals","volume":"177","author":"Al Faysal","year":"2024","journal-title":"Computers in Biology and Medicine"},{"key":"10.1016\/j.josat.2025.209749_bb0010","author":"American Society of Addiction Medicine"},{"issue":"25","key":"10.1016\/j.josat.2025.209749_bb0015","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209749_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharmaceutical Statistics"},{"key":"10.1016\/j.josat.2025.209749_bb0025","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2025.209749_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209511","article-title":"Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis","volume":"167","author":"Chan","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"9","key":"10.1016\/j.josat.2025.209749_bb0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/MLR.0000000000001165","article-title":"Chronic disease medication adherence after initiation of buprenorphine for opioid use disorder","volume":"57","author":"Chang","year":"2019","journal-title":"Medical Care"},{"issue":"9","key":"10.1016\/j.josat.2025.209749_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3111\/13696998.2014.925463","article-title":"Persistence and healthcare utilization associated with the use of buprenorphine\/naloxone film and tablet formulation therapy in adults with opioid dependence","volume":"17","author":"Clay","year":"2014","journal-title":"Journal of Medical Economics"},{"key":"10.1016\/j.josat.2025.209749_bb0045","author":"Congress.gov"},{"issue":"2","key":"10.1016\/j.josat.2025.209749_bb0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7861\/fhj.2022-0006","article-title":"A comparison of in-person versus telephone consultations for outpatient hospital care","volume":"9","author":"Crook","year":"2022","journal-title":"Future Healthcare Journal"},{"key":"10.1016\/j.josat.2025.209749_bb0055","author":"Drug Enforcement Administration"},{"key":"10.1016\/j.josat.2025.209749_bb0060","author":"Federal Register"},{"issue":"12","key":"10.1016\/j.josat.2025.209749_bb0065","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2025.209749_bb0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamapsychiatry.2018.3685","article-title":"Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X waiver","volume":"76","author":"Fiscella","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2025.209749_bb0075","author":"Foley & Lardner LLP"},{"key":"10.1016\/j.josat.2025.209749_bb0080","author":"Foundation R"},{"issue":"10","key":"10.1016\/j.josat.2025.209749_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36298","article-title":"Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic","volume":"5","author":"Frost","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209749_bb0090","author":"Greifer"},{"issue":"10","key":"10.1016\/j.josat.2025.209749_bb0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36914","article-title":"Telemedicine buprenorphine initiation and retention in opioid use disorder treatment for medicaid enrollees","volume":"6","author":"Hammerslag","year":"2023","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.josat.2025.209749_bb0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/00952990.2022.2065638","article-title":"Long-term patient outcomes following buprenorphine\/naloxone treatment for opioid use disorder: A retrospective analysis in a commercially insured population","volume":"48","author":"Hasan","year":"2022","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209749_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mlwa.2021.100144","article-title":"A machine learning framework to predict the risk of opioid use disorder","volume":"6","author":"Hasan","year":"2021","journal-title":"Machine Learning with Applications"},{"issue":"10","key":"10.1016\/j.josat.2025.209749_bb0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamapsychiatry.2022.2284","article-title":"Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2025.209749_bb0115","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2147\/NDT.S331442","article-title":"Factors that affect patient attrition in buprenorphine treatment for opioid use disorder: A retrospective real-world study using electronic health records","volume":"17","author":"Ker","year":"2021","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"10.1016\/j.josat.2025.209749_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/09595230601146603","article-title":"Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status","volume":"26","author":"Korn\u00f8r","year":"2007","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2025.209749_bb0125","author":"Landi"},{"issue":"5","key":"10.1016\/j.josat.2025.209749_bb0130","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/add.13270","article-title":"Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization","volume":"111","author":"Lo-Ciganic","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209749_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2019.07.010","article-title":"Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?","volume":"105","author":"Meinhofer","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209749_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12911-023-02348-4","article-title":"Patients\u2019 perspectives and preferences toward telemedicine versus in-person visits: A mixed-methods study on 1226 patients","volume":"23","author":"Moulaei","year":"2023","journal-title":"BMC Medical Informatics and Decision Making"},{"issue":"Suppl","key":"10.1016\/j.josat.2025.209749_bb0145","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.3122\/jabfm.2021.S1.200207","article-title":"Designing and evaluating COVID-19 protocols for an office-based opioid treatment program in an urban underserved setting","volume":"34","author":"O\u2019Gurek","year":"2021","journal-title":"Journal of the American Board of Family Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209749_bb0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2025.209749_bb0155","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid: The impact of longer treatment on health care outcomes for opioid use disorder within a key population of Medicaid enrollees","volume":"39","author":"Samples","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2025.209749_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2025.209749_bb0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1060028017751913","article-title":"Treatment persistence among insured patients newly starting buprenorphine\/naloxone for opioid use disorder","volume":"52","author":"Shcherbakova","year":"2018","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.josat.2025.209749_bb0170","author":"STROBE"},{"key":"10.1016\/j.josat.2025.209749_bb0175","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2025.209749_bb0180","author":"U.S. Drug Enforcement Administration"},{"key":"10.1016\/j.josat.2025.209749_bb0185","doi-asserted-by":"crossref","DOI":"10.1089\/tmj.2024.0410","article-title":"The association between telehealth use during buprenorphine treatment for opioid use disorder and clinical outcomes: A retrospective cohort study","author":"Vakkalanka","year":"2024","journal-title":"Telemedicine and E-Health."},{"issue":"7","key":"10.1016\/j.josat.2025.209749_bb0190","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1007\/s11606-021-06969-1","article-title":"Telehealth utilization is associated with lower risk of discontinuation of buprenorphine: A retrospective cohort study of US veterans","volume":"37","author":"Vakkalanka","year":"2022","journal-title":"Journal of General Internal Medicine"},{"issue":"22","key":"10.1016\/j.josat.2025.209749_bb0195","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209749_bb0200","first-page":"5","article-title":"Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review","volume":"23","author":"Weintraub","year":"2021","journal-title":"Heroin Addiction and Related Clinical Problems"},{"issue":"12","key":"10.1016\/j.josat.2025.209749_bb0205","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.josat.2025.209749_bb0210","author":"Wilson Sonsini Goodrich & Rosati"},{"issue":"1","key":"10.1016\/j.josat.2025.209749_bb0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/add.16684","article-title":"Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient- and prescriber-level characteristics in Massachusetts, USA","volume":"120","author":"Young","year":"2025","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2025.209749_bb0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching","volume":"7","author":"Zhang","year":"2019","journal-title":"Annals of Translational Medicine"},{"issue":"2","key":"10.1016\/j.josat.2025.209749_bb0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/ADM.0000000000000287","article-title":"Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment for opioid use disorder: A 2-year retrospective data analysis","volume":"11","author":"Zheng","year":"2017","journal-title":"Journal of Addiction Medicine"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:26:17Z","timestamp":1754425577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"alternative-id":["S2949875925001286"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209749","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of telehealth, in-person, and hybrid care modalities on buprenorphine discontinuation among patients with opioid use disorder: A retrospective cohort study on commercially insured individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209749"}}